Cargando…
Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
SARS-CoV-2 infects humans and causes Coronavirus disease 2019 (COVID-19). The S1 domain of the spike glycoprotein of SARS-CoV-2 binds to human angiotensin-converting enzyme 2 (hACE2) via its receptor-binding domain, while the S2 domain facilitates fusion between the virus and the host cell membrane...
Autores principales: | Buratto, Damiano, Saxena, Abhishek, Ji, Qun, Yang, Guang, Pantano, Sergio, Zonta, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632240/ https://www.ncbi.nlm.nih.gov/pubmed/34858396 http://dx.doi.org/10.3389/fimmu.2021.730099 |
Ejemplares similares
-
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
por: Matthews, Alicia M., et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
por: Esparza, Thomas J., et al.
Publicado: (2020) -
Improved Binding Affinity of Omicron’s Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence
por: Kumar, Rajender, et al.
Publicado: (2022) -
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
por: Ho, Tin-Yun, et al.
Publicado: (2007)